International Organ Transplantation: A Patient’s Guide to Safe and Ethical Care Abroad

For patients living with advanced organ failure, transplantation may offer an important treatment option when other therapies are no longer sufficient. But access to transplant services, waiting systems, specialized expertise and eligible transplant programs varies substantially between countries. The World Health Organization recognizes significant global differences in the availability, safety, quality and regulation of transplantation services.

These differences sometimes lead patients and families to explore international organ transplantation and seek evaluation at transplant centers outside their country of residence.

Receiving transplant care internationally, however, is fundamentally different from simply arranging another type of medical treatment abroad. Transplantation involves complex medical eligibility requirements, donor and recipient protections, national regulations, ethical safeguards and long-term follow-up.

This guide explains what patients and their families should understand before seeking transplant evaluation internationally—and how an international patient referral can begin safely and responsibly.

What is international organ transplantation?

International organ transplantation generally refers to a patient seeking transplant-related evaluation or treatment outside their country of residence.

The reasons vary. A patient may be looking for:

• access to a specialized transplant program
• evaluation by another transplant center
• treatment unavailable or limited in their home country
• expertise in a complex transplant condition
• evaluation of a potential living donor
• an additional medical opinion regarding transplant eligibility.

Crossing an international border does not itself make transplantation unethical.

The Declaration of Istanbul describes travel for transplantation as movement across jurisdictional borders for transplantation purposes. It becomes unethical transplant tourism when it involves organ trafficking, trafficking in persons for organ removal, or when resources used for non-resident patients undermine transplant services available to the local population.

That distinction is essential.

International transplant care should never mean purchasing an organ or bypassing legitimate donation, allocation, medical or legal requirements.

Who determines whether a patient can receive a transplant?

One of the most important principles for international patients to understand is that only an appropriately licensed transplant program can determine whether a patient is medically and programmatically eligible for transplantation.

A referral or navigation platform can help patients organize information, understand potential pathways and identify hospitals for evaluation. It cannot guarantee:

• acceptance for transplantation
• donor eligibility
• organ availability
• placement on a waiting list
• compatibility between a donor and recipient
• the timing of transplantation
• the clinical outcome.

The transplant center must independently evaluate the individual case.

This distinction is particularly important for patients who receive online advertisements promising a transplant within a guaranteed timeframe.

A legitimate international referral should lead to hospital evaluation—not a guaranteed organ or guaranteed transplant.

What information does a transplant center usually need?

Requirements vary by organ, country and transplant program, but international evaluation commonly begins with a review of the patient's medical history and available records.

Information may include the patient's diagnosis, previous treatments, laboratory results, imaging, current medications, previous surgeries and relevant specialist reports.

The patient's date of birth, nationality and country of residence may also be important because clinical criteria and rules governing access for non-resident patients can differ between jurisdictions.

Where living donation is being considered, the potential donor requires a separate evaluation.

Importantly, sending records for review does not mean the patient has been accepted for transplantation. It is generally the beginning of the evaluation process.

Starting an international transplant case

Patients—or a family member or other trusted person acting on their behalf—may begin by providing basic case information and available medical documents for an initial referral review.

MedTransplant helps international patients organize their transplant enquiry, identify potentially relevant transplant pathways and hospitals, and facilitate referral for independent hospital evaluation.

Which types of transplantation may involve international evaluation?

International enquiries can involve several different transplant pathways.

Kidney transplantation

Kidney transplantation is an established treatment for suitable patients with end-stage kidney disease. WHO notes that, compared with dialysis, kidney transplantation can provide advantages in survival, quality of life and cost-effectiveness.

International patients may seek evaluation involving a potential living donor, but both recipient and donor must satisfy the requirements of the transplant program and applicable laws.

Liver transplantation

Liver transplantation may be considered for selected patients with advanced acute or chronic liver failure. Eligibility requires detailed assessment of disease severity, overall health and other clinical factors.

Living-donor liver transplantation is available in some healthcare systems, subject to strict donor evaluation and local regulations.

Heart and lung transplantation

Heart and lung transplantation involve highly specialized evaluation, organ allocation and post-transplant management. International access can therefore be particularly dependent upon national allocation policies and individual transplant-center requirements.

Stem cell and bone marrow transplantation

Hematopoietic stem cell transplantation differs substantially from solid-organ transplantation. WHO reports that more than 1.5 million patients have undergone hematopoietic stem cell transplantation, primarily for hematological cancers, while its role also extends to certain non-malignant and genetic disorders.

Patients should therefore follow the pathway appropriate to their specific disease and type of transplantation rather than treating all transplant services as interchangeable.

Living donation requires protection of both patient and donor

A potential living donor is not simply a source of an organ for the recipient.

The donor is an individual whose health, autonomy and welfare must be independently protected.

WHO's Guiding Principles emphasize voluntary consent and protections for living donors, while the international ethical framework stresses safeguards against exploitation and commercialization.

A transplant center may therefore require medical testing, compatibility assessment, psychosocial evaluation, informed consent procedures and verification of the relationship and circumstances surrounding the proposed donation.

A prospective donor should also be able to withdraw from the process according to applicable medical, ethical and legal requirements.

How should patients choose a transplant hospital abroad?

The decision should go well beyond comparing price or looking at photographs of hospital facilities.

Patients should investigate whether the hospital operates an established transplant program, which transplant types it performs, whether it accepts international patients, what evaluation is required and how donor protection and follow-up are handled.

Questions should also include:

• Who performs the transplant?
• How is eligibility determined?
• What donor evaluations are required?
• What happens if the patient is found ineligible?
• How are complications managed?
• What follow-up is required after returning home?
• What national rules apply to non-resident patients?

Patients considering a particular country can additionally explore:

This creates the commercial/clinical navigation path we discussed without turning the article into an advertisement.

What is the difference between international transplant care and transplant tourism?

This distinction deserves special attention.

Legitimate travel for transplantation can occur within regulated medical and legal frameworks. The Declaration of Istanbul states that such travel becomes transplant tourism when it involves organ trafficking or trafficking in persons for organ removal, or when providing transplantation to non-residents undermines a country's ability to serve its own population.

Patients should therefore be extremely cautious about anyone offering:

• organs for sale
• guaranteed donor organs
• arrangements that conceal the donor's identity or circumstances
• payment to obtain an organ
• ways to bypass transplant regulations
• transplantation without appropriate hospital evaluation.

WHO's current transplantation policy similarly emphasizes ethical access, regulatory oversight, living-donor protection, traceability and measures against organ trafficking.

Can an international patient be guaranteed a transplant?

There is an important difference between:

and:

MedTransplant operates according to the first model.

Its role is to help patients navigate international options and facilitate communication and referral to relevant transplant hospitals. Medical eligibility, donor acceptance, organ allocation and treatment decisions remain entirely with the licensed transplant center and relevant authorities.

How MedTransplant supports international patients

Finding a transplant program internationally can be difficult because patients must navigate medical requirements, hospital policies, national regulations, documentation and communication across healthcare systems.

MedTransplant provides international transplant care navigation and patient referral support.

Depending on the case, this may include helping a patient or their trusted representative:

identify an appropriate transplant pathway; explore relevant destinations and transplant hospitals; organize available case information and medical records; and submit an enquiry for independent evaluation by an appropriate hospital.

MedTransplant does not sell, source or broker human organs and does not determine transplant eligibility.

Have a transplant case that needs international evaluation?

Patients, family members and trusted representatives can submit available information for an initial case review.

Continue exploring

Related MedTransplant guides

Hospital selection

How to Choose a Transplant Hospital Abroad: 10 Questions Patients Should Ask

Choosing a transplant hospital abroad requires more than comparing costs. Learn 10 questions about eligibility, donors, safety, ethics and follow-up before seeking international transplant care.

Read guide →

Kidney transplant

Kidney Transplant Abroad: Eligibility, Living Donors, Evaluation and Patient Safety

Considering a kidney transplant abroad? Learn about eligibility, living donor evaluation, hospital selection, safety, costs and international patient referral.

Read guide →

Living donation

Living Donor Transplantation Abroad: Medical Evaluation, Ethics and Donor Protection

Learn how living donor transplantation abroad works, including donor evaluation, consent, compatibility, ethics, legal safeguards and international patient referral.

Read guide →